Zacks Research Issues Pessimistic Forecast for PDCO Earnings

Patterson Companies, Inc. (NASDAQ:PDCO) – Investment analysts at Zacks Research cut their FY2025 earnings per share estimates for shares of Patterson Companies in a research note issued on Wednesday, March 19th. Zacks Research analyst I. Bandyopadhyay now expects that the company will earn $2.25 per share for the year, down from their prior estimate of $2.26. The consensus estimate for Patterson Companies’ current full-year earnings is $2.25 per share. Zacks Research also issued estimates for Patterson Companies’ Q1 2026 earnings at $0.32 EPS, Q4 2026 earnings at $0.91 EPS, FY2026 earnings at $2.33 EPS, Q1 2027 earnings at $0.28 EPS and Q2 2027 earnings at $0.46 EPS.

A number of other equities analysts have also commented on PDCO. Stifel Nicolaus cut their price target on Patterson Companies from $25.00 to $24.00 and set a “hold” rating for the company in a report on Thursday, December 5th. Robert W. Baird lifted their price target on Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a research note on Thursday, December 12th. Leerink Partnrs lowered Patterson Companies from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Leerink Partners restated a “market perform” rating and set a $31.35 target price (up from $29.00) on shares of Patterson Companies in a report on Wednesday, December 11th. Finally, Mizuho started coverage on Patterson Companies in a report on Wednesday, December 4th. They set a “neutral” rating and a $23.00 target price for the company. Eleven research analysts have rated the stock with a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, Patterson Companies currently has a consensus rating of “Hold” and an average price target of $26.57.

Patterson Companies Price Performance

Patterson Companies stock opened at $31.16 on Friday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The stock has a fifty day moving average of $31.04 and a 200-day moving average of $26.20. Patterson Companies has a 52 week low of $19.45 and a 52 week high of $31.79. The stock has a market capitalization of $2.76 billion, a P/E ratio of 18.22, a price-to-earnings-growth ratio of 2.71 and a beta of 0.99.

Hedge Funds Weigh In On Patterson Companies

A number of large investors have recently bought and sold shares of PDCO. Vanguard Group Inc. grew its holdings in shares of Patterson Companies by 0.5% during the fourth quarter. Vanguard Group Inc. now owns 9,409,915 shares of the company’s stock valued at $290,390,000 after buying an additional 47,897 shares during the last quarter. American Century Companies Inc. raised its stake in Patterson Companies by 24.1% in the 4th quarter. American Century Companies Inc. now owns 2,711,030 shares of the company’s stock valued at $83,662,000 after purchasing an additional 527,054 shares during the last quarter. Equity Investment Corp raised its stake in Patterson Companies by 16.6% in the 4th quarter. Equity Investment Corp now owns 2,028,964 shares of the company’s stock valued at $62,614,000 after purchasing an additional 289,295 shares during the last quarter. Charles Schwab Investment Management Inc. raised its stake in Patterson Companies by 15.8% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,799,942 shares of the company’s stock valued at $55,546,000 after purchasing an additional 245,376 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in Patterson Companies by 18.0% in the 4th quarter. Bank of New York Mellon Corp now owns 1,455,729 shares of the company’s stock valued at $44,924,000 after buying an additional 222,005 shares in the last quarter. Institutional investors own 85.43% of the company’s stock.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.